Position in GSK
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$577,511
-$30,517 QoQ
Shares Held
11,017
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#452
of 1,033 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fiduciary Alliance LLC holds $60,154,220 across 9 Drug Manufacturers - General names. GSK ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
68,948 | $17,510,723 | |
| 2 | LLY |
ELI LILLY & Co
|
11,681 | $14,010,542 | |
| 3 | PFE |
Pfizer Inc
|
422,829 | $10,181,722 | |
| 4 | AMGN |
Amgen Inc
|
25,928 | $9,389,047 | |
| 5 | ABBV |
AbbVie Inc.
|
21,965 | $5,527,272 | |
| 6 | MRK |
Merck & Co., Inc.
|
16,686 | $2,144,151 | |
| 7 | GSK |
GSK plc
This page
|
11,017 | $577,511 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,832 | $508,899 |
All Filings in GSK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $577,511 | 11,017 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $608,028 | 11,017 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $569,648 | 11,616 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $519,689 | 12,041 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $454,886 | 11,846 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $443,146 | 11,439 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $389,843 | 11,527 | Shares | Sole | 2025-01-13 | |
| 2023-06-30 | $6,272 | 176 | Shares | Sole | 2023-07-18 | |
| 2022-12-31 | $6,184 | 176 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||